Does a clinical trial render the pharmaceutical formulation used therein public?
OLG Celle on the obligations of distributors under Art. 14 MDR when distributing non-compliant medical devices in the context of unfair competition law
par Dr. Daniel Tietjen et Sherin Sayed
Is it 'unfair' for a university to own student-created IP? Reflections on OUI v ONI
par Adrian Toutoungi et Lauren Mounteney
Disproportionality in Pharma-Cases: A Follow-up
par Verena Bertram et Dr. Nora E. Wessendorf, LL.M. (Washington)
Dos & Don’ts in Research Collaborations
par Verena Bertram
Are your contracts UPC ready? How to triage your key IP agreements and templates
par plusieurs auteurs
The impact of the National Security and Investment Act 2021
par Philip Shepherd et Paolo Palmigiano
Are your contracts UPC ready? Key risks to consider
par plusieurs auteurs
Means of evidence before the UPC
par plusieurs auteurs
How do inspections work in the UPC?
par plusieurs auteurs
Should I file an infringement action with the UPC or stick to national courts?
A comparison of UPC infringement proceedings with national patent infringement proceedings
par plusieurs auteurs
Long-running issue: the distinction between cosmetic products and medicinal products by function
par Dr. Manja Epping et Sherin Sayed